A1439

Pituitary adenylate cyclase activating polypeptide-38

• Synonym(s): PACAP-38
• Empirical Formula (Hill Notation): C₂₀₃H₃₃₁N₆₃O₅₃S
• CAS Number: 137061-48-4
• Molecular Weight: 4534.26
• UNSPSC Code: 41106305
• NACRES: NA.32
• MDL number: MFCD00081800
• Form: powder

Properties

• form: powder
• Quality Segment: 200
• composition: Peptide content, ~70%
• UniProt accession no.: P18509
• storage temp.: −20°C
• Gene Information: human ... ADCYAP1(116)

Description

General description

Pituitary adenylate cyclase activating polypeptide-38 (PACAP38) is mapped to human chromosome 18. 27-residue-amidated fragment (PACAP27) comprises another isoform. The PACAP38 is major isoform associated with mammals.

Application

Pituitary adenylate cyclase activating polypeptide-38 has been used to test its effect in stimulating the formation of cyclic AMP hypothalamus and cerebral cortex slices of chicken and to treat glioblastoma cells (U87MG) in cell migration assay to test its anti-invasive effects.

Biochem/physiol Actions

Pituitary adenylate cyclase activating polypeptide-38 (PACAP38) is a cardioprotectant and may help in treating radiation-induced heart disease (RIHD). It plays a protective role during oxidative stress in cardiomyocytes. PACAP38 has antioxidant, anti-apoptotic and anti-inflammatory property. It is implicated in the pathophysiology of migraine and cluster headache.

PACAP-38 is a neuropeptide that has substantial sequence homology to vasoactive intestinal peptide (VIP). It is reported to serve as a neuronal survival factor.

Other Notes

Lyophilized from 0.1% TFA in H2O

Safety Information

• Storage Class: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)